Medication info
Sugadapa Tablets

Sugadapa Tablets

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletEvogliptin Tartrate›6.87mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
PTP (Alu-Alu) - 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202300827 · Approved 2023.03.10 · Insurance code 642507750

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medication may be administered to patients receiving evogliptin 5 mg and dapagliflozin 10 mg as 1 tablet once daily, regardless of meals (as evogliptin/dapagliflozin 5mg/10mg). Administration of this medication is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 45 mL/min/1.73m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Administration of this medication is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medicine aids in improving blood sugar control in patients with type 2 diabetes as an adjunct to dietary and exercise therapy. The combination of evogliptin and dapagliflozin helps to effectively lower blood sugar levels, facilitating smoother blood sugar management and supporting diabetes control.

Dosage and Administration

Adult dosage

This medication may be administered to patients receiving evogliptin 5 mg and dapagliflozin 10 mg as 1 tablet once daily, regardless of meals (as evogliptin/dapagliflozin 5mg/10mg). Administration of this medication is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 45 mL/min/1.73m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Administration of this medication is not recommended in patients with severe hepatic impairment.

Precautions

This medication should not be administered to certain patients. For example, individuals allergic to this drug's active ingredients or excipients, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients undergoing dialysis should not use this medication as it may pose risks. Patients with heart failure or impaired kidney function, as well as those with reduced fluid volume, should exercise caution when taking this medication. It is particularly not recommended for patients with severe heart failure, and those with reduced kidney function may experience elevated drug concentrations, requiring close monitoring of their condition. This medication is not recommended for patients with severely impaired liver function, and if there is a history of acute pancreatitis or symptoms suggestive of pancreatitis, the medication should be discontinued immediately and a physician consulted. Various adverse reactions may occur when taking this medication, including dyspepsia, infections, arthralgia, headache, dizziness, and skin rashes. Hypoglycemic symptoms may also arise, necessitating caution. One of the active ingredients, dapagliflozin, carries risks of genital infections, urinary tract infections, fluid volume depletion, and ketoacidosis; therefore, if symptoms of infection or dehydration appear, medical staff should be informed immediately. While this medication interacts minimally with other medications, the concentration may change when taken with some antibiotics or antituberculosis drugs, so it is advisable to consult with a physician or pharmacist. Pregnant or breastfeeding women are advised against using this medication, and use should be discontinued upon confirmation of pregnancy. Elderly patients may have reduced kidney or liver function, thus their condition should be closely monitored when taking this medication. In cases of overdose, there is no specific antidote; appropriate treatment should be administered based on symptoms and the medication should be stored out of reach of children.

Side effects

  • Constipation
  • chronic gastritis
  • colonic polyps
  • gastric ulcer
  • gastroesophageal reflux disease
  • hemorrhoids
  • dyspepsia
  • vaginal infections
  • herpes zoster
  • cystitis
Show 153 more
  • arthralgia
  • myalgia
  • rotator cuff syndrome
  • ligament sprain
  • dizziness
  • headache
  • sensory neural hearing loss
  • hypertension
  • vulvitis
  • genital infections
  • gastroenteritis
  • vulvovaginal candidiasis
  • increased amylase
  • increased lipase
  • increased blood urea
  • weight loss
  • hypoglycemia
  • lumbar pain
  • cerebral ischemia
  • altered taste
  • contusion
  • humeral fracture
  • joint dislocation
  • dermatitis
  • erythema
  • urticaria
  • nausea
  • headache
  • dizziness
  • altered smell
  • myalgia
  • urticaria
  • rash
  • elevated liver function tests
  • weight loss
  • dyspepsia
  • diarrhea
  • vomiting
  • urinary tract infection
  • dehydration
  • hypovolemia
  • hypotension
  • diabetic ketoacidosis
  • vertigo
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • elevated serum creatinine
  • elevated blood urea
  • weight loss
  • acute cholecystitis
  • vocal cord nodules
  • vasomotor rhinitis
  • acute stress disorder
  • anxiety disorder
  • insomnia
  • periodontitis
  • cataract
  • conjunctival hemorrhage
  • refractive disorders
  • diabetic nephropathy
  • renal cysts
  • benign prostatic hyperplasia
  • vaginal bleeding
  • acute cholecystitis
  • hypertension
  • vocal cord nodules
  • vasomotor rhinitis
  • acute stress disorder
  • anxiety disorder
  • insomnia
  • periodontitis
  • cataract
  • conjunctival hemorrhage
  • refractive disorders
  • diabetic nephropathy
  • renal cysts
  • benign prostatic hyperplasia
  • vaginal bleeding
  • acute cholecystitis
  • hypertension
  • vocal cord nodules
  • vasomotor rhinitis
  • acute stress disorder
  • anxiety disorder
  • insomnia
  • periodontitis
  • cataract
  • conjunctival hemorrhage
  • refractive disorders
  • diabetic retinopathy
  • dry eye
  • ocular pain
  • retinal disorders
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • double vision
  • eyelid edema
  • keratitis
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyps
  • tinnitus
  • anaphylactic reaction
  • food allergy
  • erythrocytosis
  • urinary tract infection
  • acute pyelonephritis
  • headache
  • sensory loss
  • sensory disturbance
  • nasopharyngitis
  • upper respiratory infection
  • weakness
  • chest pain
  • fatigue
  • chest discomfort
  • pain
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • menstrual irregularities
  • pruritus
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic ketoacidosis
  • perineal necrosis
  • vesicular pemphigoid

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

PTP (Alu-Alu) - 30 tablets/box [(10 tablets/PTP x 3)]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.